Amicus Therapeutics Inc Financial Flexibility Index
Amicus Therapeutics Inc financial flexibility index. Amicus Therapeutics Inc (FOLD) has a Financial Flexibility Index of 0.02x as of December 2025. Free cash flow of $16.55 Million (operating CF $16.25 Million minus capex $299.00K) represents 0% of total liabilities ($675.63 Million). See Amicus Therapeutics Inc (FOLD) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Amicus Therapeutics Inc (2005–2025)
Financial flexibility index of Amicus Therapeutics Inc from 2005 to 2025. Historical Financial Flexibility Index trend for Amicus Therapeutics Inc across 21 annual periods. Check FOLD cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Amicus Therapeutics Inc Financial Flexibility Index by Year (2005–2025)
Amicus Therapeutics Inc financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for Amicus Therapeutics Inc. For the full cash flow conversion analysis, see Amicus Therapeutics Inc (FOLD) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | $36.44 Million | $33.15 Million | $675.63 Million | ▲ +205.1% |
| 2024 | -0.05x | $-30.34 Million | $-33.89 Million | $590.99 Million | ▲ +48.6% |
| 2023 | -0.10x | $-61.65 Million | $-69.09 Million | $617.71 Million | ▲ +63.1% |
| 2022 | -0.27x | $-162.81 Million | $-166.57 Million | $601.12 Million | ▲ +18.5% |
| 2021 | -0.33x | $-198.61 Million | $-202.49 Million | $597.77 Million | ▲ +13.3% |
| 2020 | -0.38x | $-230.06 Million | $-233.29 Million | $600.14 Million | ▲ +37.8% |
| 2019 | -0.62x | $-230.40 Million | $-250.42 Million | $373.78 Million | ▲ +6.2% |
| 2018 | -0.66x | $-293.65 Million | $-299.95 Million | $447.04 Million | ▲ +14.6% |
| 2017 | -0.77x | $-210.96 Million | $-215.49 Million | $274.17 Million | ▼ -260.1% |
| 2016 | -0.21x | $-144.58 Million | $-150.53 Million | $676.69 Million | ▼ -25.6% |
| 2015 | -0.17x | $-95.32 Million | $-100.14 Million | $560.55 Million | ▲ +71.0% |
| 2014 | -0.59x | $-51.43 Million | $-51.67 Million | $87.79 Million | ▼ -6.3% |
| 2013 | -0.55x | $-45.10 Million | $-45.79 Million | $81.81 Million | ▲ +23.4% |
| 2012 | -0.72x | $-29.42 Million | $-33.74 Million | $40.87 Million | ▲ +39.7% |
| 2011 | -1.19x | $-48.00 Million | $-49.42 Million | $40.20 Million | ▼ -318.1% |
| 2010 | -0.29x | $-13.60 Million | $-13.98 Million | $47.62 Million | ▲ +90.7% |
| 2009 | -3.07x | $-41.56 Million | $-43.37 Million | $13.54 Million | ▼ -418.3% |
| 2008 | -0.59x | $-34.20 Million | $-36.86 Million | $57.73 Million | ▼ -338.3% |
| 2007 | 0.25x | $15.86 Million | $15.19 Million | $63.80 Million | ▲ +207.0% |
| 2006 | -0.23x | $-31.86 Million | $-33.89 Million | $137.16 Million | ▲ +0.7% |
| 2005 | -0.23x | $-15.08 Million | $-18.12 Million | $64.50 Million | — |